局部微波消融技术在乳腺癌治疗中的应用
Application of local microwave ablation in treatment of breast cancer
周文斌, 唐新宇, 王水 . 局部微波消融技术在乳腺癌治疗中的应用[J]. 外科理论与实践, 2022 , 27(05) : 403 -405 . DOI: 10.16139/j.1007-9610.2022.05.005
| [1] | Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. |
| [2] | Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial[J]. Lancet Oncol, 2014, 15(12):1303-1310. |
| [3] | Petrowsky H, Fritsch R, Guckenberger M, et al. Modern therapeutic approaches for the treatment of malignant liver tumours[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(12):755-772. |
| [4] | Ahmed M, Brace CL, Lee FT Jr, et al. Principles of and advances in percutaneous ablation[J]. Radiology, 2011, 258(2):351-369. |
| [5] | Zhou W, Zha X, Liu X, et al. US-guided percutaneous microwave coagulation of small breast cancers: a clinical study[J]. Radiology, 2012, 263(2):364-373. |
| [6] | Pan H, Qian M, Chen H, et al. Precision breast-conser-ving surgery with microwave ablation guidance: a pilot single-center, prospective cohort study[J]. Front Oncol, 2021, 11:680091. |
| [7] | Zhou W, Liang M, Pan H, et al. Comparison of ablation zones among different tissues using 2450-MHz cooled-shaft microwave antenna: results in ex vivo porcine mo-dels[J]. PLoS One, 2013, 8(8):e71873. |
| [8] | Ma G, Chen H, Xu J, et al. Discontinuous moving shot technique for conformal thermal ablation in an ex vivo porcine liver model[J]. Diagn Interv Radiol, 2021, 27(3):418-423. |
| [9] | Shi X, Pan H, Ge H, et al. Subsequent cooling-circulation after radiofrequency and microwave ablation avoids secondary indirect damage induced by residual thermal energy[J]. Diagn Interv Radiol, 2019, 25(4):291-297. |
| [10] | Zhou W, Jiang Y, Chen L, et al. Image and pathological changes after microwave ablation of breast cancer: a pilot study[J]. Eur J Radiol, 2014, 83(10):1771-1777. |
| [11] | Li C, Li C, Ge H, et al. Technical analysis of US imaging for precise microwave ablation for benign breast tumours[J]. Int J Hyperthermia, 2018, 34(8):1179-1185. |
| [12] | Zhou W, Yu M, Pan H, et al. Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer[J]. J Immunother Cancer, 2021, 9(4):e002343. |
| [13] | Zhou W, Yu M, Mao X, et al. Landscape of the periphe-ral immune response induced by local microwave ablation in patients with breast cancer[J]. Adv Sci (Weinh), 2022, 9(17):e2200033. |
| [14] | Li L, Wang W, Pan H, et al. Microwave ablation combined with OK-432 induces Th1-type response and specific antitumor immunity in a murine model of breast cancer[J]. J Transl Med, 2017, 15(1):23. |
| [15] | Zhu J, Yu M, Chen L, et al. Enhanced antitumor efficacy through microwave ablation in combination with immune checkpoints blockade in breast cancer: a pre-clinical study in a murine model[J]. Diagn Interv Imaging, 2018, 99(3):135-142. |
| [16] | Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy[J]. Science, 2015, 348(6230):69-74. |
| [17] | Mcarthur HL, Diab A, Page DB, et al. A pilot study of preoperative single-dose ipilimumab and/or cryoablation in women with early-stage breast cancer with comprehensive immune profiling[J]. Clin Cancer Res, 2016, 22(23):5729-5737. |
| [18] | Ho AY, Barker CA, Arnold BB, et al. A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer[J]. Cancer, 2020, 126(4):850-860. |
| [19] | Voorwerk L, Slagter M, Horlings HM, et al. Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial[J]. Nat Med, 2019, 25(6):920-928. |
| [20] | Schmid P, Rugo HS, Adams S, et al. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial[J]. Lancet Oncol, 2020, 21(1):44-59. |
| [21] | Yu M, Pan H, Che N, et al. Microwave ablation of primary breast cancer inhibits metastatic progression in model mice via activation of natural killer cells[J]. Cell Mol Immunol, 2021, 18(9):2153-2164. |
/
| 〈 |
|
〉 |
